Company: VCYT
Filing Date: 2025-02-28
Form Type: 10-K
Source: 0001384101-25-000014
Chunk: 169

Company: VERACYTE, INC.
Filing Date: 2025-02-28
Form: 10-K
Item: Item 8
Chunk 169
---
)Accounts payable(4,305)(134)152 Accrued liabilities and deferred revenue3,541 (676)(3,920)Net cash provided by operating activities75,096 44,222 7,535 Investing activities   Purchase of short-term investments(50,000)(19,700)(33,519)Proceeds from sale of short-term investments— 39,773 — Proceeds from maturity of short-term investments— 5,000 12,681 Acquisition of C2i, net of cash acquired5,012 — — Purchases of property, plant and equipment(11,287)(9,961)(8,549)Net cash provided by (used in) investing activities(56,275)15,112 (29,387)Financing activities   Payment of contingent consideration for acquisition(4,500)— — Payment of long-term debt— — (1,281)Payment of taxes on vested restricted stock units(10,589)(6,741)(3,167)Proceeds from the exercise of common stock options and employee stock purchases19,993 9,578 7,942 Net cash provided by financing activities4,904 2,837 3,494 Increase (decrease) in cash, cash equivalents and restricted cash23,725 62,171 (18,358)Effect of foreign currency on cash, cash equivalents and restricted cash(424)163 (592)Net increase (decrease) in cash, cash equivalents and restricted cash23,301 62,334 (18,950)Cash, cash equivalents and restricted cash at beginning of year217,330 154,996 173,946 Cash, cash equivalents and restricted cash at end of year$240,631 $217,330 $154,996 Supplementary cash flow information of non-cash investing and financing activities:   Purchases of property and equipment included in accounts payable and accrued liabilities$1,186 $966 $— Supplementary cash flow information:Cash paid for interest on debt$— $— $9 Cash paid for tax$2,236 $1,697 $570 

Cash, Cash Equivalents and Restricted Cash:

December 31, 202420232022Cash and cash equivalents$239,087 $216,454 $154,247 Restricted cash1,544 876